We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

Back to rankings

170 hedge funds and large institutions have $1.61B invested in NxStage Medical Inc. in 2016 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 45 increasing their positions, 72 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

27,700% more call options, than puts

Call options by funds: $834K | Put options by funds: $3K

94% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 17

9% more funds holding

Funds holding: 156 → 170 (+14)

0% more capital invested

Capital invested by funds: $1.6B → $1.61B (+$5.77M)

10% less funds holding in top 10

Funds holding in top 10: 10 → 9 (-1)

38% less repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 72

Holders
170
Holders Change
+14
Holders Change %
+8.97%
% of All Funds
4.25%
Holding in Top 10
9
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-10%
% of All Funds
0.23%
New
33
Increased
45
Reduced
72
Closed
17
Calls
$834K
Puts
$3K
Net Calls
+$831K
Net Calls Change
-$12.4M

Top Buyers

1
PCM
Pennant Capital Management
New Jersey
+$37.8M
2
NCGI
Next Century Growth Investors
Minnesota
+$14M
3
PC
Polar Capital
United Kingdom
+$7.42M
4
PA
Perceptive Advisors
New York
+$6.39M
5
Marshall Wace
Marshall Wace
United Kingdom
+$5.64M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$47.6M
2
TA
Tamarack Advisers
California
-$17.5M
3
Millennium Management
Millennium Management
New York
-$13.8M
4
Victory Capital Management
Victory Capital Management
Texas
-$11.5M
5
Goldman Sachs
Goldman Sachs
New York
-$11.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$193M -$47.6M -1,926,505 -21%
GGHC
2
Gilder Gagnon Howe & Co
New York
$151M -$3.49M -140,948 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$127M +$3.69M +149,086 +3%
DM
4
Deerfield Management
New York
$112M +$3.93M +159,021 +4%
OIM
5
Oracle Investment Management
Connecticut
$71.3M +$1.23M +49,700 +2%
Invesco
6
Invesco
Georgia
$66M -$199K -8,040 -0.3%
BFA
7
BlackRock Fund Advisors
California
$54.6M +$5.02M +202,835 +11%
PA
8
Perceptive Advisors
New York
$50.5M +$6.39M +258,286 +15%
PCM
9
Pennant Capital Management
New Jersey
$50.5M +$37.8M +1,530,043 +385%
BIT
10
BlackRock Institutional Trust
California
$45.3M +$1.72M +69,607 +4%
CAM
11
Cortina Asset Management
Wisconsin
$35.8M -$2.85M -115,179 -8%
Jennison Associates
12
Jennison Associates
New York
$34.8M +$536K +21,686 +2%
Victory Capital Management
13
Victory Capital Management
Texas
$34.7M -$11.5M -465,070 -26%
Wells Fargo
14
Wells Fargo
California
$32.6M -$521K -21,048 -2%
State Street
15
State Street
Massachusetts
$31.7M +$652K +26,359 +2%
WRF
16
Waddell & Reed Financial
Kansas
$29.2M +$639K +25,850 +2%
SAM
17
Sectoral Asset Management
Quebec, Canada
$23.4M -$7.63M -308,556 -26%
Massachusetts Financial Services
18
Massachusetts Financial Services
Massachusetts
$22.1M -$3.26M -131,865 -14%
William Blair & Company
19
William Blair & Company
Illinois
$21.8M -$653K -26,385 -3%
Northern Trust
20
Northern Trust
Illinois
$21.8M +$182K +7,344 +0.9%
O
21
OppenheimerFunds
New York
$21.8M +$875K +35,386 +4%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$16.7M -$569K -23,016 -3%
PCM
23
Portolan Capital Management
Massachusetts
$15.1M +$1.09M +44,021 +8%
NCGI
24
Next Century Growth Investors
Minnesota
$14.8M +$14M +565,814 New
Geode Capital Management
25
Geode Capital Management
Massachusetts
$14.8M +$1.83M +74,046 +15%
1
2 3 4 5

NXTM Hedge Fund Activity: Q4 2016 in Review

170 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q4 2016, worth a combined $1.61B — up 0.36% from $1.6B a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new NXTM positions and 17 closed out — a net gain of 16 holders — while 45 added to existing stakes and 72 trimmed.

The largest buyer was Pennant Capital Management, adding an estimated $37.8M. The largest seller was Fidelity Investments, cutting an estimated $47.6M.

  • 170 institutional investors held NxStage Medical Inc. (NXTM) as of Q4 2016, up from 156 in Q3 2016.
  • Funds reported $1.61B of NxStage Medical Inc. stock for Q4 2016, up 0.36% quarter-over-quarter.
  • 33 funds opened new NxStage Medical Inc. positions in Q4 2016 and 17 closed out, a net change of +16 holders.
  • The largest NxStage Medical Inc. buyer in Q4 2016 was Pennant Capital Management, an estimated $37.8M added.
  • The largest NxStage Medical Inc. seller in Q4 2016 was Fidelity Investments, an estimated $47.6M sold.

Based on aggregated 13F filings for Q4 2016.